Current:Home > MarketsIntel's stock did something it hasn't done since 2022 -InvestTomorrow
Intel's stock did something it hasn't done since 2022
View
Date:2025-04-28 00:50:47
The last couple of years have been terrific for semiconductor stocks. Well, most semiconductor stocks, that is. Since OpenAI introduced ChatGPT to the world on Nov. 30, 2022, shares of Nvidia and Advanced Micro Devices have risen by 721% and 83%, respectively. By contrast, shares of chip peer Intel (NASDAQ: INTC)have fallen by 25% during this time period.
There's no doubt that Intel has faced a number of challenges over the last couple of years as its cohorts swiftly move past it in the AI revolution. However, after taking a close look at Intel's price movement, there could be some reasons to believe the stock is positioned for a rebound.
Below, I'm going to explore something that Intel's stock hasn't done since 2022 and make the case for why I'm cautiously optimistic that better days could be in store for the chipmaker.
A close look at Intel's valuation
The chart below illustrates Intel's price-to-sales (P/S) ratio over the last three years. The first thing that I noticed is that it bottomed around 1.5 sometime between August and September. The last time Intel's P/S ratio reached this level was back in 2022 — coincidentally, around the same months in 2022 as well.
INTC PS Ratio data by YCharts
On the surface, investors might think that Intel stock has bottomed and that shares are destined to repeat the upward movements seen in 2023. However, smart investors understand that history is not an indication of future performance. One has to look for actual catalysts — and I see several potential ones right now that could help the stock rebound.
Index funds:This simple strategy would have beaten the pros this year.
Why I think Intel could rebound
As I pointed out above, Intel's P/S ratio bottomed somewhere around August and September 2022 and then subsequently went on a run for the ages. You know what else happened during this time period? President Biden signed the CHIPS and Science Act into law on Aug. 9, 2022. And do you know what company has been a major beneficiary of the CHIPS Act? It's Intel.
Over the last two years, Intel has been awarded tens of billions of dollars in grants and loans as part of CHIPS Act funding. While this looks great on the surface, there are a couple of caveats. Namely, companies rarely receive federal funding the moment an award or grant is announced. In other words, it can take a long time to actually receive this funding. Moreover, sometimes the original dollar amount that was awarded can change.
The unfortunate reality is that it's taken quite some time for Intel to actually begin receiving some of this funding, and some is coming in at slightly lower dollar amounts than initially expected. In my eyes, Intel stock's run in 2023 was driven by a combination of broader euphoria surrounding artificial intelligence (AI) coupled with optimism that the CHIPS Act would benefit the company.
While reality has set in throughout 2024, I still see a couple of reasons for Intel stock to bounce back. First, President-elect Trump campaigned on the promise of bringing manufacturing jobs back to America from overseas. Moreover, it is no secret that AI-powered chips are a hot commodity — and one that requires increased scrutiny as it relates to the defense sector and the U.S. military.
On top of this, Intel CEO Pat Gelsinger recently announced that he's retiring. Since Gelsinger took the chief executive position at Intel in February 2021, the stock has generated a total return of negative53%. With a track record like that, it was time for a change. I think new leadership in combination with a new administration focused on domestic manufacturing and American business could bode well for Intel.
INTC Total Return Level data by YCharts
Is Intel stock a buy right now?
In all honesty, I'm quite torn on investing in Intel. While the stock appears to be rebounding ever so slightly from its P/S multiple's low point, I can't quite fully buy into the idea that the company is going to turn things around.
While I remain optimistic about its potential, I need more concrete evidence that Intel is actually moving forward. At the end of the day, CHIPS Act funding, the potential of a new administration investing in America, and plans for a new CEO are just too vague.
At best, I see Intel as a speculative buy right now. But with all of this said, I will definitely be keeping an eye on the company as 2025 could very well be the start of another run for the chipmaker.
Adam Spatacco has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel and Nvidia. The Motley Fool recommends the following options: short February 2025 $27 calls on Intel. The Motley Fool has a disclosure policy.
The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY.
Don’t miss this second chance at a potentially lucrative opportunity
Offer from the Motley Fool:Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
- Nvidia:if you invested $1,000 when we doubled down in 2009,you’d have $376,324!*
- Apple: if you invested $1,000 when we doubled down in 2008, you’d have $46,022!*
- Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $491,327!*
Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.
See 3 “Double Down” stocks »
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
veryGood! (832)
Related
- A South Texas lawmaker’s 15
- Idaho Murders Case: Judge Enters Not Guilty Plea for Bryan Kohberger
- Air Pollution Particles Showing Up in Human Placentas, Next to the Fetus
- Why the VA in Atlanta is throwing 'drive-through' baby showers for pregnant veterans
- Paige Bueckers vs. Hannah Hidalgo highlights women's basketball games to watch
- Edgy or insensitive? The Paralympics TikTok account sparks a debate
- Abortion policies could make the Republican Party's 'suburban women problem' worse
- How a Contrarian Scientist Helped Trump’s EPA Defy Mainstream Science
- Breaking debut in Olympics raises question: Are breakers artists or athletes?
- Planning a trip? Here's how to avoid fake airline ticket scams
Ranking
- US Open player compensation rises to a record $65 million, with singles champs getting $3.6 million
- Basketball powers Kansas and North Carolina will face each other in home-and-home series
- Florida's abortion laws protect a pregnant person's life, but not for mental health
- Sun's out, ticks out. Lyme disease-carrying bloodsucker season is getting longer
- Police remove gator from pool in North Carolina town: Watch video of 'arrest'
- Top CDC Health and Climate Scientist Files Whistleblower Complaint
- The Luann and Sonja: Welcome to Crappie Lake Trailer Is More Wild Than We Imagined
- San Francisco, Oakland Sue Oil Giants Over Climate Change
Recommendation
Clay Aiken's son Parker, 15, makes his TV debut, looks like his father's twin
Why anti-abortion groups are citing the ideas of a 19th-century 'vice reformer'
Khartoum's hospital system has collapsed after cease-fire fails
Planning a trip? Here's how to avoid fake airline ticket scams
Selena Gomez engaged to Benny Blanco after 1 year together: 'Forever begins now'
Fear of pregnancy: One teen's story in post-Roe America
Sun's out, ticks out. Lyme disease-carrying bloodsucker season is getting longer
We’re Investigating Heat Deaths and Illnesses in the Military. Tell Us Your Story.